Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account
Loading more articles
policy

CDC says Americans who tested positive no longer must isolate for five days under certain conditions; FDA grants emergency use authorization to the first at-home test detecting both the flu and COVID-19.

view more »
policy

The Food and Drug Administration approves Paxlovid to treat COVID-19 in adults; a National Institutes of Health study sheds new light on long COVID-19.

view more »
policy

FDA authorizes the first at-home nasal test that detects influenza A and B as well as COVID-19; Moderna reaches a $400 million agreement with the National Institutes of Health.

view more »
policy

National Institutes of Health research finds that Black and Hispanic Americans face greater long COVID-19 risks, the CDC says that primary series vaccination protects children ages 3–5 for four months, and Novavax will deliver an additional 1.5 million doses.

view more »
policy

New COVID-19 vaccine initiatives seek to address access inequalities, and NIH launches a website where Americans can self-report COVID-19 test results anonymously to provide data to public health departments.

view more »
policy

HHS links COVID-19 vaccinations to fewer COVID-19 hospitalizations and deaths, and NIH details its plan to study long COVID-19 effects.

view more »
policy

WHO announces new names for SARS-CoV-2 variants of concern; two NIH studies show that mRNA vaccines are safe for pregnant people.

view more »
policy

FDA Commissioner Stephen Hahn, MD, says drug and biological product centers will publicly post reviews of the data and information supporting emergency use authorizations (EUAs) for all drug and biological products, including vaccines, as part of the agency's COVID-19 response.

view more »
policy

An interim analysis of Moderna Inc.'s COVID-19 vaccine shows promising results; CDC guidance highlights that wearing a mask can protect the wearer.

view more »
policy

FDA grants emergency use authorization for an Eli Lilly antibody treatment; a Pfizer vaccine has promising early results; President-elect Biden names a COVID-19 advisory board.

view more »
policy

NIH will study experimental COVID-19 treatments and support the development of six new testing technologies; FDA's vaccine committee will meet Oct. 22.

view more »
policy

A panel convened by the National Institutes of Health culminated in an evidence report that includes 26 recommendations for improving implementation of proven services to reduce disparities in preventable conditions.

view more »
policy

Three essential hospitals will join the National Institutes of Health's Justice Community Opioid Innovation Network to research quality addiction treatment for opioid use disorder in jails, drug courts, and other criminal justice settings.

view more »
Load More
Previous Next
Close
Test Caption
Test Description goes like this